Haoran Zhang - Publications

Radiotherapy-Associated Pain in Head and Neck Cancer: From Clinical Burden to Neuroimmune Modulator.

Journal: Journal of clinical medicine

Published: May 21, 2026

Dynamic Time-Resolved Remodeling of the Immune Microenvironment After Resistance to BRAF/MEK Inhibitors in Melanoma: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies.

Journal: International journal of molecular sciences

Published: April 17, 2026

Management of locally-advanced dermatofibrosarcoma protuberans: Four cases report.

Journal: Medicine

Published: September 10, 2025

The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study.

Journal: World journal of urology

Published: November 09, 2023

Risk factors and novel predictive model for metastatic cutaneous squamous cell carcinoma: a population-based analysis.

Journal: Archives of dermatological research

Published: December 28, 2022

Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: A systemic review and meta-analysis.

Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)

Published: June 25, 2022

Efficacy of second-line ICIs combined with TKIs among patients with metastatic renal cell carcinoma: a real-world study.

Journal: Immunotherapy

Published: February 21, 2022

Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma.

Journal: Cancer management and research

Published: July 03, 2021

Clinical outcomes of second-line treatment following first-line VEGFR-TKI failure in patients with metastatic renal cell carcinoma: a comparison of axitinib alone and axitinib plus anti-PD-1 antibody.

Journal: Cancer communications (London, England)

Published: March 14, 2021

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma.

Journal: Nature communications

Published: March 04, 2021

Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.

Journal: BJU international

Published: February 20, 2021

The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer.

Journal: The Prostate

Published: February 14, 2021